# EDGAR Filing Document

**Accession Number:** 0001598646
**File Stem:** 0001623632-25-001475
**Filing Date:** 2025-10
**Character Count:** 40186
**Document Hash:** bb715383e03caf989b4aa14cca348015
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001623632-25-001475.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0001623632-25-001475

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 6

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Minerva Neurosciences, Inc.
- **CENTRAL INDEX KEY:** 0001598646
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 260784194
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88240
- **FILM NUMBER:** 251425442

**BUSINESS ADDRESS:**
- **STREET 1:** 1500 DISTRICT AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
- **BUSINESS PHONE:** 617-600-7373

**MAIL ADDRESS:**
- **STREET 1:** 1500 DISTRICT AVENUE
- **CITY:** BURLINGTON
- **STATE:** MA
- **ZIP:** 01803
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FEDERATED HERMES, INC.
- **CENTRAL INDEX KEY:** 0001056288
- **STANDARD INDUSTRIAL CLASSIFICATION:** INVESTMENT ADVICE [6282]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 251111467
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 1001 LIBERTY AVENUE
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15222
- **BUSINESS PHONE:** 4122881900

**MAIL ADDRESS:**
- **STREET 1:** 1001 LIBERTY AVENUE
- **CITY:** PITTSBURGH
- **STATE:** PA
- **ZIP:** 15222

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEDERATED INVESTORS INC /PA/
- **DATE OF NAME CHANGE:** 20200130

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEDERATED HERMES, INC.
- **DATE OF NAME CHANGE:** 20200130

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FEDERATED INVESTORS INC /PA/
- **DATE OF NAME CHANGE:** 19980219

## Ex-99

Annex A

ITEM 6 CLASSIFICATION OF REPORTING PERSONS

Identity and Classification of Each Reporting Person

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;IDENTITY | &nbsp;&nbsp;**Citizenship** | &nbsp;&nbsp;**Principal Occupation or Employment** | &nbsp;&nbsp;CLASSIFICATION UNDER ITEM 3 |
| &nbsp;&nbsp;Federated Hermes Equity Funds |  |  | &nbsp;&nbsp;(d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) |
| &nbsp;&nbsp;Federated Hermes Insurance Series |  |  | &nbsp;&nbsp;(d) Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8) |
| &nbsp;&nbsp;Federated Equity Management Company of Pennsylvania |  |  | &nbsp;&nbsp;(e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 |
| &nbsp;&nbsp;Federated Global Investment Management Corp. |  |  | &nbsp;&nbsp;(e) Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 |
| &nbsp;&nbsp;Federated Hermes, Inc. |  |  | &nbsp;&nbsp;(g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) |
| &nbsp;&nbsp;FII Holdings, Inc. |  |  | &nbsp;&nbsp;(g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) |
| &nbsp;&nbsp;Voting Shares Irrevocable Trust |  |  | &nbsp;&nbsp;(g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) |
| &nbsp;&nbsp;Thomas R. Donahue | &nbsp;&nbsp;United States | &nbsp;&nbsp;CFO of FHI | &nbsp;&nbsp;(g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) |
| &nbsp;&nbsp;Ann C. Donahue | &nbsp;&nbsp;United States | &nbsp;&nbsp;Trustee of the Irrevocable Voting Trust | &nbsp;&nbsp;(g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) |
| &nbsp;&nbsp;J. Christopher Donahue | &nbsp;&nbsp;United States | &nbsp;&nbsp;CEO of FHI | &nbsp;&nbsp;(g) parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) |

---

Federated Hermes, Inc. (the "<u>Parent</u>") is filing this schedule 13D because it is the parent holding company of Federated Equity Management Company of Pennsylvania and Federated Global Investment Management Corp. (the "<u>Investment Advisers</u>"), which act as investment advisers to registered investment companies that own shares of common stock in MINERVA NEUROSCIENCES, INC. (the "<u>Reported Securities</u>"). The Investment Advisers are wholly owned subsidiaries of FII Holdings, Inc., which is wholly owned subsidiary of Federated Hermes, Inc., the Parent. All of the Parent's outstanding voting stock is held in the Voting Shares Irrevocable Trust (the "Trust") for which Thomas R. Donahue, Ann C. Donahue and J. Christopher Donahue act as trustees (collectively, the "<u>Trustees</u>"). The Trustees have joined in filing this Schedule 13D because of the collective voting control that they exercise over the Parent. In accordance with Rule 13d-4 under the Securities Act of 1934, as amended, the Parent, the Trust, and each of the Trustees declare that this statement should not be construed as an admission that they are the beneficial owners of the Reported Securities, and the Parent, the Trust, and each of the Trustees expressly disclaim beneficial ownership of the Reported Securities.

## Ex-99

EXHIBIT "1"

AGREEMENT FOR JOINT FILING OF

SCHEDULE 13D

The following parties hereby agree to file jointly the statement on Schedule 13D to which this Agreement is attached and any amendments thereto which may be deemed necessary pursuant to Regulation 13D-G under the Securities Exchange Act of 1934:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Federated Hermes, Inc. as parent holding company of the investment advisers to registered investment companies that beneficially own the securities.

Voting Shares Irrevocable Trust, as holder of all the voting shares of Federated Hermes, Inc.

Thomas R. Donahue, individually and as Trustee

Ann C. Donahue, individually and as Trustee

J. Christopher Donahue, individually and as Trustee

It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other parties unless such party knows or has reason to believe that such information is incomplete or inaccurate.

It is understood and agreed that the joint filing of Schedule 13D shall not be construed as an admission that the reporting persons named herein constitute a group for purposes of Regulation 13D-G of the Securities Exchange Act of 1934, nor is a joint venture for purposes of the Investment Company Act of 1940.

Date: OCTOBER 28, 2025

---

| | |
|:---|:---|
| &nbsp;&nbsp;By: | &nbsp;&nbsp;/s/J. Christopher Donahue |
| &nbsp;&nbsp;Name/Title: | &nbsp;&nbsp;J. Christopher Donahue, as President of Federated Hermes, Inc. |
| &nbsp;&nbsp;By: | &nbsp;&nbsp;/s/Thomas R. Donahue |
| &nbsp;&nbsp;Name/Title | &nbsp;&nbsp;Thomas R. Donahue, individually and as Trustee of Voting Shares Irrevocable Trust. |
| &nbsp;&nbsp;By: | &nbsp;&nbsp;/s/Ann C. Donahue |
| &nbsp;&nbsp;Name/Title | &nbsp;&nbsp;Ann C. Donahue, individually and as Trustee of Voting Shares Irrevocable Trust |
| &nbsp;&nbsp;By: | &nbsp;&nbsp;/s/J. Christopher Donahue |
| &nbsp;&nbsp;Name/Title | &nbsp;&nbsp;J. Christopher Donahue, individually and as Trustee of Voting Shares Irrevocable Trust |

---

1. The number of shares indicated represent shares beneficially owned by registered investment companies advised by subsidiaries of Federated Hermes, Inc. that have been delegated the power to direct investment and power to vote the securities by the registered investment companies' board of trustees or directors. All of the voting securities of Federated Hermes, Inc. are held in the Voting Shares Irrevocable Trust ("Trust"), the trustees of which are Thomas R. Donahue, Ann C. Donahue and J. Christopher Donahue ("Trustees"). In accordance with Rule 13d-4 under the 1934 Act, the Trust, Trustees, and parent holding company declare that the filing of this statement should not be construed as an admission that any of the investment advisers, parent holding company, Trust, and Trustees are beneficial owners (for the purposes of Sections 13(d) and/or 13(g) of the Act) of any securities covered by this statement, and such advisers, parent holding company, Trust, and Trustees expressly disclaim that they are the beneficial owners of such securities.

## Ex-99

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints J. Christopher Donahue their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for them and in their names, place and stead, in any and all capacities, to sign and any and all Schedule 13Ds and/or Schedule 13Gs, and any amendments thereto, to be filed with the Securities and Exchange Commission pursuant to Regulation 13D-G of the Securities Exchange Act of 1934, as amended, by means of the Securities and Exchange Commission's electronic disclosure system known as EDGAR; and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to sign and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as each of them might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue thereof.

SIGNATURES

<u>/s/ Thomas R. Donahue</u>

Thomas R. Donahue

TITLE OR CAPACITY

Individually and as Trustee of the Voting Shares Irrevocable Trust

Sworn to and subscribed before me this <u>31<sup>st</sup></u> day of <u>March,</u> 2017.

<u>/s/ Melissa Lamparski Bamonte</u>

Notary Public

Print Name: <u>Melissa Lamparski Bamonte</u>

My Commission Expires: <u>February 4, 2018</u>

(Notary Stamp)

Commonwealth of Pennsylvania – Notarial Seal

Melissa Lamparski Bamonte, Notary Public

City of Pittsburgh, Allegheny County

My commission expires February 4, 2018

Member, Pennsylvania Association of Notaries

## Ex-99

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints J. Christopher Donahue their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution for them and in their names, place and stead, in any and all capacities, to sign and any and all Schedule 13Ds and/or Schedule 13Gs, and any amendments thereto, to be filed with the Securities and Exchange Commission pursuant to Regulation 13D-G of the Securities Exchange Act of 1934, as amended, by means of the Securities and Exchange Commission's electronic disclosure system known as EDGAR; and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to sign and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as each of them might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue thereof.

SIGNATURES

<u>/s/ Ann C. Donahue</u>

Ann C. Donahue

TITLE OR CAPACITY

Individually and as Trustee of the Voting Shares Irrevocable Trust

Sworn to and subscribed before me this <u>10<sup>th</sup></u> day of <u>January,</u> 2023.

<u>/s/ Deanna L. Marley</u>

Notary Public

Print Name: <u>Deanna L. Marley</u>

My Commission Expires: <u>June 14, 2024</u>

(Notary Stamp)

Commonwealth of Pennsylvania – Notary Seal

Deanna L. Marley, Notary Public

Allegheny County

My commission expires June 14, 2024

Commission number 1102414

Member, Pennsylvania Association of Notaries

## Ex-99

**Exhibit "2"**

**SUPPORT AGREEMENT**

This **SUPPORT AGREEMENT** (this "**Agreement**"), dated as of October 21, 2025, is made by and between Minerva Neurosciences, Inc., a

Delaware corporation (the "**Company**"), and the undersigned holder of shares of the Company (the "**Investor**"). The Company and the Investor shall be referred to herein from time to time collectively as the "**Parties**." Capitalized terms used but not otherwise defined herein shall have the meanings

ascribed to such terms in the Purchase Agreement (as defined below).

WHEREAS, the Company and certain investors (the "**Purchasers**"), severally and not jointly, entered into that certain Securities Purchase Agreement, dated as of the date hereof (as it may be amended, restated or otherwise modified from time to time in accordance with its terms, the "**Purchase Agreement**");

WHEREAS, as of the date of this Agreement, the Investor owns that number of shares of common stock, par value $0.0001 per share, of the

Company (the "**Common Stock**") and/or that number of shares of Series A Preferred Stock, par value $0.0001 per share, of the Company (together with the Common Stock, the "**Voting Securities**") set forth opposite its name on Exhibit A hereto; and

WHEREAS, the Purchase Agreement contemplates that the Parties will enter into this Agreement concurrently with the entry into the Purchase

Agreement, and pursuant to this Agreement, the Investor will vote in favor of approval of the Proposals (as defined in the Purchase Agreement).

NOW, THEREFORE, in consideration of the premises and the mutual promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

1. *Agreement to Vote*.

For so long as this Agreement is in effect, the Investor hereby agrees to appear (in person or by proxy) and vote (in person or by proxy) at any meeting of the stockholders of the Company, and in any action by written resolution of the stockholders of the Company (such meeting or written resolution, the "**Meeting**"), all of such Investor's Voting Securities that such Investor holds of record or beneficially, as of the date of this Agreement, or of which such Investor acquires record or beneficial ownership after the date hereof and before the record date of the Meeting (collectively, the "**Subject Equity Securities**") in favor of the Proposals, and against any proposal that conflicts or materially impedes or interferes with the approval of any of the Proposals or that would adversely affect or delay the consummation of the transactions contemplated by the Purchase Agreement. The Investor shall validly execute and deliver to the Company, on (or effective as of) the fifth (5<sup>th</sup>) Business Day following the date that the Proxy Statement related to the Proposals is disseminated by the Company to the Company's stockholders, a properly completed voting proxy in the form distributed by or on behalf of the Company in favor of the Proposals. In the event of any equity dividend or distribution, or any change in the equity interests of the Company by reason of any equity dividend or distribution, equity split, recapitalization, combination, conversion, exchange of equity interests or the like prior to the Closing, the term "**Subject Equity Securities**" shall be deemed to refer to and include the Subject Equity Securities as well as all such equity dividends and distributions and any securities into which or for which any or all of the Subject Equity Securities may be changed or exchanged or which are received in such transaction.

2. *Transfer of Shares*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) From the date hereof until the earlier of (i) the Automatic Conversion Date (as defined in the Certificate of Designation) or (ii) the valid termination of this Agreement pursuant to <u>Section 3</u> (the "**Restriction Termination**"), the Investor hereby agrees that the Investor shall not, directly or indirectly, (i) sell, assign, transfer (including by operation of law), place a lien on, pledge, dispose of or otherwise encumber any of his, her or its Subject Equity Securities or otherwise agree to do any of the foregoing, other than to affiliates of the Investor for no consideration (each, a "**Transfer**"), (ii) deposit any of the Investor's Subject Equity Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect to any of the Investor's Subject Equity Securities that conflicts with any of the covenants or agreements set forth in this Agreement, (iii) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect sale, assignment, transfer (including by operation of law) or other disposition of any of the Investor's Subject Equity Securities, (iv) engage in any hedging or other transaction which is designed to, or which would (either alone or in connection with one or more events or developments (including the satisfaction or waiver of any conditions precedent)), lead to or result in a sale or disposition of the Investor's Subject Equity Securities or (v) take any action that would have the effect of preventing or materially delaying the performance of the Investor's obligations hereunder, except as affirmatively permitted by the Purchase Agreement; *provided*, *however*, that the foregoing shall not apply to any Transfer by virtue of the Investor's organizational documents upon liquidation or dissolution of the Investor; *provided*, that any transferee of any Transfer must enter into a written agreement in form and substance reasonably satisfactory to the Company agreeing to be bound by this Agreement prior to the occurrence of such Transfer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In furtherance of the foregoing, the Company hereby agrees to (i) place a revocable stop order on all Subject Equity Securities subject to <u>Section 2(a)</u>, including those which may be covered by a registration statement, and (ii) notify the Company's transfer agent in writing of such stop order and the restrictions on such Subject Equity Securities under <u>Section 2(a)</u> and direct the Company's transfer agent not to process any attempts by the Investor to Transfer any Subject Equity Securities except in compliance with <u>Section 2(a)</u>. For the avoidance of doubt, the obligations of the Company under this <u>Section 2(b)</u> shall be deemed to be satisfied by the existence of any similar stop order and restrictions currently existing on the Subject Equity Securities. Upon the earlier of the Restriction Termination or termination of this Agreement pursuant to Section 3, the Company shall instruct its transfer agent to remove the stop order placed on the Subject Equity Securities pursuant to this Section 2(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. *Termination*. This Agreement shall automatically terminate, without any notice or other action by either Party, and be void *ab initio* upon the earlier of (a) the Automatic Conversion Date (as defined in the Certificate of Designation); and (b) three (3) years following the Closing Date (as defined in the Purchase Agreement). Upon termination of this Agreement as provided in the immediately preceding sentence, neither of the Parties shall have any further obligations under, or with respect to, this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. *Amendments and Waivers*. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by (i) the Company, and (ii) the Purchasers of at least a majority in interest of the Securities, if prior to the Closing Date, to be purchased by the Purchasers under the Purchase Agreement, or, if after the Closing Date, still held by the Purchasers. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. *Incorporation by Reference*. Sections 6.3 (*Notices*), 6.5 (*Construction*), 6.6 (*Successors and Assigns*), 6.7 (*No Third-Party Beneficiaries*), 6.8 (*Governing Law*), 6.10 (*Execution*), 6.11 (*Severability*) and 6.14 (*Remedies*) of the Purchase Agreement are incorporated herein and shall apply to this Agreement *mutatis mutandis*.

[Signature page follows]

**IN WITNESS WHEREOF**, each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

**COMPANY:**

**Minerva Neurosciences, Inc.**

By:

Name:

Title:

**INVESTOR:**

**[NAME OF INVESTOR]**

By:

Name:

Title:

[Signature page to Support Agreement]

**Exhibit A**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  |  | **Shares of Common** | **Stock** | **Shares of Series A** | **Preferred** |
| **Investor** | **Name** | **Beneficially Owned** |  | **Stock Beneficially** | **Owned** |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Minerva Neurosciences, Inc.**

*(Name of Issuer)*

**Common Stock**

*(Title of Class of Securities)*

**603380205**

*(CUSIP Number)*

**Stephen Van Meter**<br>Federated Hermes, Inc.<br>1001 Liberty Avenue<br>Pittsburgh PA 15222-3779<br>1-412-288-1046

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/21/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **603380205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Federated Hermes, Inc.** | Name of reporting person<br>**Federated Hermes, Inc.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**PENNSYLVANIA** | Citizenship or place of organization<br>**PENNSYLVANIA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.32%** | Percent of class represented by amount in Row (11)<br>**19.32%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**HC** | Type of Reporting Person (See Instructions)<br>**HC** | |

---

| **CUSIP No.** | **603380205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Voting Shares Irrevocable Trust** | Name of reporting person<br>**Voting Shares Irrevocable Trust** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**PENNSYLVANIA** | Citizenship or place of organization<br>**PENNSYLVANIA** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.32%** | Percent of class represented by amount in Row (11)<br>**19.32%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

| **CUSIP No.** | **603380205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Thomas R. Donahue** | Name of reporting person<br>**Thomas R. Donahue** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1351275.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.32%** | Percent of class represented by amount in Row (11)<br>**19.32%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

| **CUSIP No.** | **603380205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Ann C. Donahue** | Name of reporting person<br>**Ann C. Donahue** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1351275.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.32%** | Percent of class represented by amount in Row (11)<br>**19.32%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

| **CUSIP No.** | **603380205** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**J. Christopher Donahue** | Name of reporting person<br>**J. Christopher Donahue** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1351275.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1351275.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | Aggregate amount beneficially owned by each reporting person<br>**1351275.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**19.32%** | Percent of class represented by amount in Row (11)<br>**19.32%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock

**(b) Name of Issuer:**
Minerva Neurosciences, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
1500 District Avenue, Burlington, MA, 01803

**Item 4. Purpose of Transaction**

The shares of the Issuer were originally acquired separately by certain mutual funds (the "Managed Funds") advised by an Advisory Subsidiary of FHI for investment in the ordinary course of business and not with the purpose nor with the effect of changing or influencing the control of the issuer.  A Schedule 13G with respect to such acquisition was previously filed with the Commission on January 18, 2024.   On October 21, 2025, the Issuer entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain accredited investors (the "Investors"), acting severally and not jointly, including the Managed Funds, pursuant to which the Issuer agreed to issue and sell, in a private placement (the "Private Placement") Series A Convertible Preferred Stock, tranche A warrants to acquire shares of Series A Preferred Stock ("Tranche A Warrants") and tranche B warrants to acquire shares of Series A Preferred Stock ("Tranche B Warrants") for an aggregate offering price of up to $200 million. The closing of the Private Placement occurred on October 23, 2025. In the Private Placement, the Managed Funds separately acquired an aggregate of 8,500 shares of Series A Convertible Preferred Stock exercisable for 4,020,500  shares of common stock, Tranche A Warrants exercisable for 8,500 shares of Series A Convertible Preferred Stock, and Tranche B Warrants exercisable for 4,250 shares of Series A Convertible Preferred Stock (such securities, collectively, the "Private Placement Securities").  Concurrently with the execution of the Securities Purchase Agreement and as a condition to closing of the Private Placement, each of the Managed Funds entered into a support agreement (each, a "Support Agreement" and, collectively, the "Support Agreements") providing, among other things, that such stockholders will vote all of their shares of common stock: in favor of (i) the issuance of shares of common stock upon conversion of the Series A Preferred Stock, (ii) an increase to the reserved shares under the Issuer's Amended and Restated 2013 Equity Incentive Plan, and (iii) other customary annual stockholder meeting matters (together, the "Proposals"), and against any proposal that conflicts or materially impedes or interferes with the approval of any of the Proposals or that would adversely affect or delay the consummation of the transactions contemplated by the Securities Purchase Agreement. Additionally, pursuant to the Support Agreements, each Managed Fund is restricted from selling or otherwise transferring any of its voting securities in the Issuer prior to the stockholder meeting at which the Proposals will be voted upon.  A form of Support Agreement is filed as Exhibit 2 hereto. The foregoing summary of the terms of the Support Agreements is subject to, and qualified in its entirety by, the full text of the Support Agreement, which is incorporated herein by reference.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on the number of shares of Common Stock outstanding as of August 8, 2025 reported by the Issuer on the Form 10-Q for the quarterly period ended June 30, 2025.

**(b)**
The information set forth in rows 7 through 13 of the cover pages to this Schedule 13D is incorporated by reference.

**(c)**
The Managed Funds have not effected any transaction in the shares of Common Stock of the Issuer during the past 60 days except with respect to the Private Placement described above.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information set forth in Item 4 is hereby incorporated herein by reference.  Form of Support Agreements is attached and is incorporated herein by reference.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Federated Hermes, Inc.

**Signature:** /s/J. Christopher Donahue

**Name/Title:** J. Christopher Donahue, as President of Federated Hermes, Inc.

**Date:** 10/28/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Voting Shares Irrevocable Trust

**Signature:** /s/Thomas R. Donahue

**Name/Title:** Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust

**Date:** 10/28/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Thomas R. Donahue

**Signature:** /s/Thomas R. Donahue

**Name/Title:** Thomas R. Donahue

**Date:** 10/28/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Ann C. Donahue

**Signature:** /s/Ann C. Donahue

**Name/Title:** Ann C. Donahue

**Date:** 10/28/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** J. Christopher Donahue

**Signature:** /s/J. Christopher Donahue

**Name/Title:** J. Christopher Donahue

**Date:** 10/28/2025